Key facts
- This page summarizes Guiffre Christopherd T.'s Form 4 filing for Pear Therapeutics, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jan 2023, 16:03.
Guiffre Christopherd T. - 14 Jan 2023 Form 4 Insider Report for Pear Therapeutics, Inc.
- Reporting relationship
- CFO, COO, Treas., & Asst. Sec.
- Issuer ticker
- N/A
- Reported as of
- 14 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2023, 16:03:10 UTC
- Prior SEC filing
- 18 Feb 2022
- Next SEC filing
- 24 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stacie S. Aarestad, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Guiffre Christopherd T. filed Form 4 for Pear Therapeutics, Inc. on 18 Jan 2023.
Change
- Previous filing in this sequence was filed on 18 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PEARQ
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +49,500
- Change %
- Price
- $0.000000
- Shares after
- 49,500
- Date
- 14 Jan 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PEARQ
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -49,500
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 100,500
- Date
- 14 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 49,500
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
Footnote F2
The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.